evernoaBASE

Point of Care Testing Device

Information

evernoaBASE is a point of care device which measures the fraction exhaled of nitric oxide (FeNO). FeNo is an exhaled biomarker which measures in an objective way the inflammation of the airway, which is a common symptom of different respiratory diseases, such as asthma. Thus, this device is really useful in order to diagnosis and also monitoring asthmatic patients, enhancing not only their lives but also making easier the medical practitioners work. evernoaBASE is an accurate and rapid device (gives the results in only 5seconds), providing the healthcare professionals objective information to diagnosis asthma. The test is no invasive due to the patient only has to exhale through the mouthpiece.

Product Information

https://www.evernoa.com/en/

Visit ID (prod)

0pvo7sjgqa7wn

EVERSENS SLZ3.H36Eversens is specialized in the design, development and manufacture of solutions for the analysis of human breath. Eversens designs and builds best-in-class products that, through a non-invasive detection of exhaled biomarkers, help to optimize both the diagnosis and control and monitoring of chronic airway diseases, thus improving the quality of life of people, and achieving the sustainability of healthcare systems. The entrepreneurial team of our company is made up of a highly qualified and complementary team with experience in leading and developing R&D projects, with worldwide responsibilities in the development of new products and in supporting their industrialization.